Share price and RNS

To view the latest share price data and regulatory news service announcements for Sareum plc please click on the links below.

Sareum Holdings News and Articles from

Proactive Investors logo

RNS press release - Additional disclosure concerning Michael Owen
29th July 2019
RNS press release - Additional Funds Raised
28th June 2019
News - Sareum notes decision by Sierra Oncology to explore options for future development of SRA737
27th June 2019
Sierra Oncology is exploring non-dilutive strategic options to support the continued development of its portfolio of DNA damage response (DDR) assets, including SRA737. SRA737, which is a checkpoint kinase 1 (Chk1) inhibitor, was originally discove…
RNS press release - Sierra seeks strategic options for SRA737
27th June 2019
News - Sareum raises £680k as it looks to take its TYK2/JAK1 inhibitors into the clinic next year
26th June 2019
Sareum Holdings PLC (LON:SAR) has raised £681,000 which it will use to advance its TYK2/JAK1 inhibitor programme towards human trials. The drug developer sold 170.37mln new shares at 0.4p as part of the fundraising, which was carried out on t…
50

  • @Sareumplc Latest tweet

    RT @HybridanLLP: Good plain English article looking at the autoimmune opportunities for Tyk2 inhibitors. The @Sareumplc compounds which ar… via @Sareumplc
    View more

Contact

Sareum Limited
Unit 2A, Langford Arch
London Road, Pampisford
Cambridge CB22 3FX
United Kingdom


tel: +44 (0) 1223 497700
fax: +44 (0) 1223 497701
email_white.png

Downloads

Final Results 2019  Brochure Sept 2019

Annual Report 2019  Notice of AGM 2019   

Annual Report 2019      Brochure     NoM